Search research articles
Contact Us
Filters
Showing results (41-50 of 190) with videos related to
Page
of 19
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 13, 2022
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness Analysis
Peter J Neumann, Louis P Garrison, Richard J Willke
International Journal of General Medicine
|
December 1, 2022
Value Insider Season 1 Episode 5: What Other Aspects of Value May Be Relevant? (Societal Impact) [Podcast]
Louis P Garrison, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers
Journal of Managed Care & Specialty Pharmacy
|
October 31, 2019
Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy
Louis P Garrison, Peter J Neumann, Richard J Willke
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]
Peter J Neumann, Richard J Willke, Louis P Garrison
BMC Research Notes
|
March 18, 2010
A review of data needed to parameterize a dynamic model of measles in developing countries
Emily K Szusz, Louis P Garrison, Chris T Bauch
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions
Kai Yeung, Kangho Suh, Louis P Garrison, et al.
Value in Health Regional Issues
|
December 12, 2018
Value-Based Pricing in Latin America: How Far Away Are We?
Aurelio Mejía, Ramiro Gilardino, Finn Børlum Kristensen, et al.
The Journal of Urology
|
April 8, 2014
Resource utilization and costs associated with the diagnostic evaluation of nonrefluxing primary hydronephrosis in infants
Ardavan Akhavan, Margarett Shnorhavorian, Louis P Garrison, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2012
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature
Russell Becker, Carole Dembek, Leigh Ann White, et al.
Journal of Comparative Effectiveness Research
|
September 10, 2024
Why is the market design for innovative pharmaceuticals not well understood?
Francisco Olivença, Jose Diaz, Sreeram V Ramagopalan, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 190) with videos related to
Sort By:
Page
of 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 13, 2022
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness Analysis
Peter J Neumann, Louis P Garrison, Richard J Willke
International Journal of General Medicine
|
December 1, 2022
Value Insider Season 1 Episode 5: What Other Aspects of Value May Be Relevant? (Societal Impact) [Podcast]
Louis P Garrison, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers
Journal of Managed Care & Specialty Pharmacy
|
October 31, 2019
Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy
Louis P Garrison, Peter J Neumann, Richard J Willke
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]
Peter J Neumann, Richard J Willke, Louis P Garrison
BMC Research Notes
|
March 18, 2010
A review of data needed to parameterize a dynamic model of measles in developing countries
Emily K Szusz, Louis P Garrison, Chris T Bauch
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions
Kai Yeung, Kangho Suh, Louis P Garrison, et al.
Value in Health Regional Issues
|
December 12, 2018
Value-Based Pricing in Latin America: How Far Away Are We?
Aurelio Mejía, Ramiro Gilardino, Finn Børlum Kristensen, et al.
The Journal of Urology
|
April 8, 2014
Resource utilization and costs associated with the diagnostic evaluation of nonrefluxing primary hydronephrosis in infants
Ardavan Akhavan, Margarett Shnorhavorian, Louis P Garrison, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2012
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature
Russell Becker, Carole Dembek, Leigh Ann White, et al.
Journal of Comparative Effectiveness Research
|
September 10, 2024
Why is the market design for innovative pharmaceuticals not well understood?
Francisco Olivença, Jose Diaz, Sreeram V Ramagopalan, et al.
Page
of 19